NDC 71872-7324-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7324
- Requested NDC
- 71872-7324-01
- Package NDCs from labels
- 71872-7324-1, 71872-7324-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2024-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7324-1 | Cleocin Phosphate | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 1 | |
| 71872-7324-1 | Cleocin Phosphate | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7324 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 1 | Current NDC, 2 package rows | 20240307_12ee0720-9979-3162-e063-6394a90a8003.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | e8086cf9-aa52-4aa5-815b-c76e8f145e0b | 2023-07-17 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE | Bryant Ranch Prepack | ac7f5c47-a06a-495f-a914-13c930106c8d | 2023-07-17 | Warnings, Adverse reactions | EH6D7113I8 |
| Cleocin Phosphate | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 896a046f-95d0-100e-e053-2a95a90aa59c | 2023-05-15 | Boxed warning, Warnings, Adverse reactions | NDA050441 1737581 1737582 EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 9e500a08-0339-eb6b-e053-2a95a90a130c | 2023-05-10 | Boxed warning, Warnings, Adverse reactions | 1737578 EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 9e4fc2d5-985a-3734-e053-2995a90aef5b | 2023-05-10 | Boxed warning, Warnings, Adverse reactions | 1737244 EH6D7113I8 |
| Cleocin Phosphate | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 9e549ceb-00e8-64b8-e053-2a95a90aef0f | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | NDA050441 205964 706461 EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 9e545c9d-dc39-584c-e053-2995a90afda4 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | 205964 EH6D7113I8 |
| Cleocin Phosphate | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | 9e5365a0-dd47-264a-e053-2a95a90a7fb8 | 2023-05-09 | Boxed warning, Warnings, Adverse reactions | NDA050441 1737578 1737579 EH6D7113I8 |
| Clindamycin | CLINDAMYCIN PHOSPHATE | Medical Purchasing Solutions, LLC | dc8b8a09-3eed-1998-e053-2995a90a2f60 | 2023-05-02 | Boxed warning, Warnings, Adverse reactions | 1737581 EH6D7113I8 |
| Clindamycin Phosphate and Tretinoin | CLINDAMYCIN PHOSPHATE AND TRETINOIN | Actavis Pharma, Inc. | 79e1c8f6-59cd-4efa-9efa-0762d4b1a10c | 2023-02-27 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | 6f72b852-e741-48e5-b8e1-f8a1afcfb4d4 | 2023-02-01 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindacin | CLINDAMYCIN PHOSPHATE | Medimetriks Pharmaceuticals, Inc. | d01ffda3-1913-400d-a899-58b8face8936 | 2022-11-21 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Zydus Pharmaceuticals USA Inc. | 83d52507-99a1-4461-b067-5ec01dc6c5d3 | 2022-10-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE, BENZOYL PEROXIDE | Padagis Israel Pharmaceuticals Ltd | 221de6a3-c1d7-4dcf-a47b-51edaa682c2a | 2022-10-01 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | 2e6f96d0-d928-4775-a7db-3e998fce675b | 2022-04-06 | Warnings, Adverse reactions | EH6D7113I8 |
| Acanya | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bausch Health US, LLC | 3dcd2c96-72b1-4a9f-b65c-08198d63b7df | 2020-09-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Oceanside Pharmaceuticals | edae294f-cc8b-4f94-8d90-4c764fda307b | 2020-09-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate 1.2% and Tretinoin 0.025% | CLINDAMYCIN PHOSPHATE AND TRETINOIN | Oceanside Pharmaceuticals | 63b2e85d-8fe5-4f18-9e85-8492c49a7520 | 2020-04-01 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindagel | CLINDAMYCIN | Bausch Health US, LLC | f7b4e985-719a-4547-b624-94612d520991 | 2020-01-01 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.